Meg Harrold
Curtin University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Meg Harrold.
Annals of the American Thoracic Society | 2016
Claire J. Tipping; Michael Bailey; Rinaldo Bellomo; Sue Berney; Heidi Buhr; Linda Denehy; Meg Harrold; Anne E. Holland; Alisa Higgins; Theodore J. Iwashyna; Dale M. Needham; Jeffrey J. Presneill; Manoj Saxena; Elizabeth H. Skinner; Steve Webb; Paul Young; Jennifer M. Zanni; Carol L. Hodgson
RATIONALE The ICU Mobility Scale (IMS) is a measure of mobility milestones in critically ill patients. OBJECTIVES This study aimed to determine the validity and responsiveness of the IMS from a prospective cohort study of adults admitted to the intensive care unit (ICU). METHODS Construct and predictive validity were assessed by comparing IMS values at ICU discharge in 192 patients to other variables using Spearman rank correlation coefficient, Mann-Whitney U tests, and logistic regression. Responsiveness was assessed using change over time, effect size, floor and ceiling effects, and percentage of patients showing change. MEASUREMENTS AND MAIN RESULTS The IMS at ICU discharge demonstrated a moderate correlation with muscle strength (r = 0.64, P < 0.001). There was a significant difference between the IMS at ICU discharge in patients with ICU-acquired weakness (median, 4.0; interquartile range, 3.0-5.0) compared with patients without (median, 8.0; interquartile range, 5.0-8.0; P < 0.001). Increasing IMS values at ICU discharge were associated with survival to 90 days (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.14-1.66) and discharge home (OR, 1.16; 95% CI, 1.02-1.32) but not with return to work at 6 months (OR, 1.09; 95% CI, 0.92-1.28). The IMS was responsive with a significant change from study enrollment to ICU discharge (d = 0.8, P < 0.001), with IMS values increasing in 86% of survivors during ICU admission. No substantial floor (14% scored 0) or ceiling (4% scored 10) effects were present at ICU discharge. CONCLUSIONS Our findings support the validity and responsiveness of the IMS as a measure of mobility in the ICU.
British Journal of Sports Medicine | 2018
Darren Hickey; Veronica Solvig; Vinicius Cavalheri; Meg Harrold; Leanda McKenna
Background It is unclear whether the presence of scapular dyskinesis increases the risk of developing shoulder pain in asymptomatic athletes. Objectives To determine whether the presence of scapular dyskinesis in asymptomatic athletes increases the risk of developing shoulder pain by systematic review and meta-analysis. Methods A systematic search was conducted in the Cochrane Library, Embase, PubMed, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database and SPORTDiscus. Prospective studies that assessed athletes for scapular dyskinesis and recorded incidents of shoulder pain were included. Study quality was assessed using the Downs and Black checklist. Meta-analysis was conducted to derive a pooled risk ratio (RR) for the development of shoulder pain in athletes with scapular dyskinesis compared with those without scapular dyskinesis. Results Five studies were included with a total of 419 athletes. Of the athletes with scapular dyskinesis, 35% (56/160) experienced shoulder pain during the follow-up, whereas 25% (65/259) of athletes without scapular dyskinesis experienced symptoms. The presence of scapular dyskinesis at baseline indicated a 43% increased risk of a shoulder pain event over a 9 to 24 months follow-up (RR=1.43, 95% CI 1.05 to 1.93). Conclusions Athletes with scapular dyskinesis have 43% greater risk of developing shoulder pain than those without scapular dyskinesis.
Physiotherapy Theory and Practice | 2018
Hiroki Saito; Meg Harrold; Vinicius Cavalheri; Leanda McKenna
ABSTRACT The relationship between subacromial pain syndrome (SAPS) and altered scapular movement has been previously reported. The purpose of this review was to determine the effect of interventions that focus on addressing scapular components to improve shoulder pain, function, shoulder range of motion (ROM), and muscle strength in adults with SAPS. Databases searched in September 2016 were: PubMed, the Cochrane Central Register of Controlled Trials [Central], EMBASE [via Ovid] and PEDro. All studies selected for this review were randomized controlled trials. In total, six studies met the inclusion criteria and were included in the meta-analyses. In adults with SAPS, scapular focused interventions significantly improved pain with activities (MD [95% CI] = −0.88 [−1.19 to −0.58], I2 43%) and shoulder function (−11.31 [−17.20 to −5.41] I2 65%) in the short term. No between-group difference in shoulder pain and function were found at follow up (4 weeks). A between-group difference in shoulder abduction ROM in the short term only was found (12.71 [7.15 to 18.26]°, I2 36%). No between-group difference in flexion ROM, supraspinatus muscle strength, pectoralis minor length or forward shoulder posture were found. In conclusion, in adults with SAPS, scapular focused interventions can improve short-term shoulder pain and function.
Heart & Lung | 2018
Claire J. Tipping; Anne E. Holland; Meg Harrold; Tom Crawford; Nick Halliburton; Carol L. Hodgson
Background: The intensive care unit mobility scale (IMS) is reliable, valid and responsive. Establishing the minimal important difference (MID) of the IMS is important in order to detect clinically significant changes in mobilization. Objective: To calculate the MID of the IMS in intensive care unit patients. Methods: Prospective multi center observational study. The IMS was collected from admission and discharge physiotherapy assessments. To calculate the MID we used; anchor based methods (global rating of change) and two distribution‐based methods (standard error of the mean and effect size). Results: We enrolled 184 adult patients; mean age 62.0 years, surgical, trauma, and medical. Anchor based methods gave a MID of 3 with area under the curve 0.94 (95% CI 0.89‐0.97). The two distribution based methods gave a MID between 0.89 and 1.40. Conclusion: These data increase our understanding of the clinimetric properties of the IMS, improving its utility for clinical practice and research.
Intensive Care Medicine | 2017
Claire J. Tipping; Meg Harrold; Anne E. Holland; Lorena Romero; Travis Nisbet; Carol L. Hodgson
Critical Care | 2015
Meg Harrold; Lisa Salisbury; Steve Webb; Garry Allison
Australian Critical Care | 2017
Charissa S.L. Tan; Meg Harrold; Kylie Hill
Physiotherapy | 2015
C.S.L. Tan; Meg Harrold; Kylie Hill
Australian Critical Care | 2018
Claire J. Tipping; T. Chan; Meg Harrold; Anne E. Holland; Carol L. Hodgson
Archive | 2016
Meg Harrold; Lisa Salisbury; Steve Webb; Garry Allison